tiprankstipranks
Trending News
More News >
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
Advertisement

Akebia Therapeutics (AKBA) Similar Stocks

Compare
1,515 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Akebia Therapeutics
$2.85
$787.48M
122.66%
3 Buy
0 Hold
0 Sell
Strong Buy
Oruka Therapeutics
$22.62
$983.65M
-20.54%
8 Buy
0 Hold
0 Sell
Strong Buy
Theravance Biopharma
$14.44
$722.68M
61.74
79.16%
4 Buy
2 Hold
0 Sell
Moderate Buy
Vir Biotechnology
$6.05
$786.27M
-17.46%
8 Buy
0 Hold
0 Sell
Strong Buy
ProKidney
$2.96
$853.42M
90.64%
3 Buy
2 Hold
1 Sell
Moderate Buy
ArriVent BioPharma, Inc.
$19.31
$809.35M
-23.09%
7 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKBA
Akebia Therapeutics
2.85
1.57
122.66%
ORKA
Oruka Therapeutics
22.62
-5.84
-20.52%
TBPH
Theravance Biopharma
14.44
6.38
79.16%
VIR
Vir Biotechnology
6.05
-1.28
-17.46%
PROK
ProKidney
3.26
1.55
90.64%
AVBP
ArriVent BioPharma, Inc.
20.82
-6.25
-23.09%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis